Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Mosaic ImmunoEngineering (CPMV) just unveiled an announcement.
Mosaic ImmunoEngineering, Inc. has revised the employment agreement with its CFO, Paul Lytle, transitioning him to a part-time role with a maximum of eight hours monthly for a $1,600 fee starting June 1, 2024. Additionally, Lytle’s accrued unpaid salary will be compensated following a successful capital raise of at least $4 million, at which point he will also receive restricted stock units amounting to 20% of this deferred salary.
Learn more about CPMV stock on TipRanks’ Stock Analysis page.